JP2012188414A - エトリコキシブの中間体、1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノンの調製方法の改良 - Google Patents
エトリコキシブの中間体、1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノンの調製方法の改良 Download PDFInfo
- Publication number
- JP2012188414A JP2012188414A JP2012002845A JP2012002845A JP2012188414A JP 2012188414 A JP2012188414 A JP 2012188414A JP 2012002845 A JP2012002845 A JP 2012002845A JP 2012002845 A JP2012002845 A JP 2012002845A JP 2012188414 A JP2012188414 A JP 2012188414A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- reaction
- methylpyridin
- ethanone
- carried out
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 59
- YBFHILNBYXCJKD-UHFFFAOYSA-N 1-(6-methylpyridin-3-yl)-2-(4-methylsulfonylphenyl)ethanone Chemical compound C1=NC(C)=CC=C1C(=O)CC1=CC=C(S(C)(=O)=O)C=C1 YBFHILNBYXCJKD-UHFFFAOYSA-N 0.000 title claims abstract description 25
- MNJVRJDLRVPLFE-UHFFFAOYSA-N etoricoxib Chemical compound C1=NC(C)=CC=C1C1=NC=C(Cl)C=C1C1=CC=C(S(C)(=O)=O)C=C1 MNJVRJDLRVPLFE-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004945 etoricoxib Drugs 0.000 title abstract 2
- -1 4-substituted-phenylmethyl sulfide Chemical class 0.000 claims abstract description 15
- PVRYOKQFLBSILA-UHFFFAOYSA-N 1-(6-methylpyridin-3-yl)ethanone Chemical compound CC(=O)C1=CC=C(C)N=C1 PVRYOKQFLBSILA-UHFFFAOYSA-N 0.000 claims abstract description 11
- 150000003462 sulfoxides Chemical class 0.000 claims abstract description 3
- 150000003457 sulfones Chemical class 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 45
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 30
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 22
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 19
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 17
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 14
- 239000012018 catalyst precursor Substances 0.000 claims description 10
- 239000003446 ligand Substances 0.000 claims description 10
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 8
- 239000003054 catalyst Substances 0.000 claims description 7
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 7
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 7
- 235000011009 potassium phosphates Nutrition 0.000 claims description 7
- NKVINJAPLKEYQS-UHFFFAOYSA-N 5-ethynyl-2-methylpyridine Chemical compound CC1=CC=C(C#C)C=N1 NKVINJAPLKEYQS-UHFFFAOYSA-N 0.000 claims description 6
- 229910052763 palladium Inorganic materials 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- NSSSVJYQTZRVMH-UHFFFAOYSA-N (6-methylpyridin-3-yl) trifluoromethanesulfonate Chemical compound CC1=CC=C(OS(=O)(=O)C(F)(F)F)C=N1 NSSSVJYQTZRVMH-UHFFFAOYSA-N 0.000 claims description 4
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 claims description 4
- QFMZQPDHXULLKC-UHFFFAOYSA-N 1,2-bis(diphenylphosphino)ethane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1 QFMZQPDHXULLKC-UHFFFAOYSA-N 0.000 claims description 4
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-Bis(diphenylphosphino)propane Substances C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 230000001590 oxidative effect Effects 0.000 claims description 4
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 claims description 4
- JKDRQYIYVJVOPF-FDGPNNRMSA-L palladium(ii) acetylacetonate Chemical compound [Pd+2].C\C([O-])=C\C(C)=O.C\C([O-])=C\C(C)=O JKDRQYIYVJVOPF-FDGPNNRMSA-L 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 239000004210 ether based solvent Substances 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims 2
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 21
- 230000015572 biosynthetic process Effects 0.000 abstract description 9
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 abstract 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 239000000047 product Substances 0.000 description 21
- 239000000543 intermediate Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- FJLFSYRGFJDJMQ-UHFFFAOYSA-N 1-bromo-4-methylsulfonylbenzene Chemical compound CS(=O)(=O)C1=CC=C(Br)C=C1 FJLFSYRGFJDJMQ-UHFFFAOYSA-N 0.000 description 8
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 5
- 229910052786 argon Inorganic materials 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- QCTITLPDUACHDS-UHFFFAOYSA-N 1-(6-methylpyridin-3-yl)-2-(4-methylsulfanylphenyl)ethanone Chemical compound C1=CC(SC)=CC=C1CC(=O)C1=CC=C(C)N=C1 QCTITLPDUACHDS-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229940111134 coxibs Drugs 0.000 description 3
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 2
- NNBYTRDSKTZTGA-UHFFFAOYSA-N 1-(2-methylpyridin-3-yl)ethanone Chemical compound CC(=O)C1=CC=CN=C1C NNBYTRDSKTZTGA-UHFFFAOYSA-N 0.000 description 2
- CEBKHWWANWSNTI-UHFFFAOYSA-N 2-methylbut-3-yn-2-ol Chemical compound CC(C)(O)C#C CEBKHWWANWSNTI-UHFFFAOYSA-N 0.000 description 2
- WADSJYLPJPTMLN-UHFFFAOYSA-N 3-(cycloundecen-1-yl)-1,2-diazacycloundec-2-ene Chemical compound C1CCCCCCCCC=C1C1=NNCCCCCCCC1 WADSJYLPJPTMLN-UHFFFAOYSA-N 0.000 description 2
- DHLUJPLHLZJUBW-UHFFFAOYSA-N 6-methylpyridin-3-ol Chemical compound CC1=CC=C(O)C=N1 DHLUJPLHLZJUBW-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 125000005595 acetylacetonate group Chemical group 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000007813 chromatographic assay Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical compound [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- NSLOBCYFRMBVDZ-UHFFFAOYSA-N 1-(6-methylpyridin-3-yl)-2-(4-methylsulfinylphenyl)ethanone Chemical compound C1=NC(C)=CC=C1C(=O)CC1=CC=C(S(C)=O)C=C1 NSLOBCYFRMBVDZ-UHFFFAOYSA-N 0.000 description 1
- FHKJOUWSBPZXTN-UHFFFAOYSA-N 1-(6-methylpyridin-3-yl)ethenol Chemical compound CC1=CC=C(C(O)=C)C=N1 FHKJOUWSBPZXTN-UHFFFAOYSA-N 0.000 description 1
- YEUYZNNBXLMFCW-UHFFFAOYSA-N 1-bromo-4-methylsulfanylbenzene Chemical compound CSC1=CC=C(Br)C=C1 YEUYZNNBXLMFCW-UHFFFAOYSA-N 0.000 description 1
- QGHDLJAZIIFENW-UHFFFAOYSA-N 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxy-3-prop-2-enylphenyl)propan-2-yl]-2-prop-2-enylphenol Chemical group C1=C(CC=C)C(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C(CC=C)=C1 QGHDLJAZIIFENW-UHFFFAOYSA-N 0.000 description 1
- 101150003085 Pdcl gene Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000006254 arylation reaction Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000007333 cyanation reaction Methods 0.000 description 1
- 238000007256 debromination reaction Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002085 enols Chemical group 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- JCDWETOKTFWTHA-UHFFFAOYSA-N methylsulfonylbenzene Chemical compound CS(=O)(=O)C1=CC=CC=C1 JCDWETOKTFWTHA-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- PENAXHPKEVTBLF-UHFFFAOYSA-L palladium(2+);prop-1-ene;dichloride Chemical compound [Pd+]Cl.[Pd+]Cl.[CH2-]C=C.[CH2-]C=C PENAXHPKEVTBLF-UHFFFAOYSA-L 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 150000003003 phosphines Chemical class 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 125000003375 sulfoxide group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- GEPJPYNDFSOARB-UHFFFAOYSA-N tris(4-fluorophenyl)phosphane Chemical compound C1=CC(F)=CC=C1P(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 GEPJPYNDFSOARB-UHFFFAOYSA-N 0.000 description 1
- WXAZIUYTQHYBFW-UHFFFAOYSA-N tris(4-methylphenyl)phosphane Chemical compound C1=CC(C)=CC=C1P(C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 WXAZIUYTQHYBFW-UHFFFAOYSA-N 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/127—Preparation from compounds containing pyridine rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
【解決手段】1−(6−メチルピリジン−3−イル)エタノンと、4−置換−フェニルメチルスルフィド、スルフォキシド、又はスルホンとを反応させるステップを含む方法により、上記中間体を調製する。
【選択図】なし
Description
本発明の目的は、COX−2阻害薬の医薬原体(pharmaceutical active ingredient)である、エトリコキシブ(Etoricoxib)合成の中間体、1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノンを調製する方法である。
CAS登録番号(RN)221615−75−4を有する、式(I):
の1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノンは、COX−2阻害薬の分類に属する医薬原体であり、かつ登録商標アルコキシア(Arcoxia)で2002年から市販されている、エトリコキシブ合成用の重要な中間体である。
本発明が取り上げる問題は、1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノンを調製する代替方法の提供である。
本発明は、式(I):
の1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノン又はその塩を調製する方法であって、式(II):
の1−(6−メチルピリジン−3−イル)エタノンと、式(III):
の4−置換−フェニルメチルスルホンとを反応させることを含む方法に関する。
の1−(6−メチルピリジン−3−イル)エテノールであるそれらの「エノール」型でも存在することができる。
の中間体1−(6−メチルピリジン−3−イル)エタノンは、式(IV):
の5−エチニル−2−メチルピリジンの水和反応により調製できることが好都合である。
の中間体5−エチニル−2−メチルピリジンの合成は、式(V):
の中間体6−メチルピリジン−3−イルトリフルオロメタンスルホネートと2−メチル−3−ブチン−2−オールとの反応を含む方法により行うことができる。
で表され、所望により容易に分離される。
と反応させることができる。
の化合物1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルファニル)フェニル]エタノン、又は式(VI−ビス):
の化合物1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルフィニル)フェニル]エタノンを得るために、前記したとおりである。
(例1)−式(V)の中間体6−メチルピリジン−3−イルトリフルオロメタンスルホネートの合成−本発明の典型例
1H−NMR(CDCl3)δ:2.61(s,3H)、7.26(d、J=8.4Hz、1H)、7.52(dd、J=9.0、3.0Hz、1H)、8.47(d、J=3.0Hz、1H)。
1H−NMR(CDCl3)δ:2.55(s,3H)、3.15(s、1H)、7.10(d、J=7.9Hz、1H)、7.64(dd、J=7.9、2.13Hz、1H)、8.60(d、J=3.0Hz、1H)。
1H−NMR(CDCl3)δ:2.64(s,3H)、3.04(s、3H)、
4.38(s、2H)、7.29(d、J=8.2Hz、1H)、7.46(d、J=8.3Hz、2H)、7.91(d、J=8.3Hz、2H)、8.16(dd、J=8.2、2.2Hz、1H)、9.11(d、J=2.2Hz、1H)、(図2を参照)。
得られた懸濁液を濾過し、生成物を水(4×320mL、4×4vol)で洗浄し、真空中65℃で乾燥した。ストローイエローの固体として、精製した式(I)の化合物(71.7g;89.6%)を収穫した。
Claims (23)
- 式(I):
の1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノン又はその塩を調製する方法であって、下記のステップ:(a)式(II):
の1−(6−メチルピリジン−3−イル)エタノンと、式(III−ビス):
の4−置換−フェニルメチルスルフィド、スルホキシド、又はスルホン(式中、nは0と2の間に含まれる整数であり、Xは、F、Br、Cl、I、OTs、OTf、OMs、ONf、及びO(C=O)NR2からなる群から選ばれ、ここでRは直鎖の、若しくは分枝したC1−C4アルキル置換基、又はフェニル、若しくはベンジルである)とを反応させるステップと;(b)nが0又は1である時、式(VI):
又は式(VI−ビス):
の関連中間体を更に酸化して式(I)の生成物を得るステップとを含む方法。 - 式(III−ビス)の化合物が、2に等しいnを有する、即ち式(III):
(式中、Xは請求項1に記載のとおりである)である、請求項1に記載の方法。 - Xが臭素である、請求項1〜2のいずれか一項に記載の方法。
- 反応が、トルエン、キシレン、アルコール類、ジオキサン及びTHFなどのエーテル溶剤、Me−THF、DMF、DMSO、並びにNMPからなる群から選ばれた有機溶剤中で行われる、又はTHF、NMP、若しくはDMF中で行われる、請求項1〜3のいずれか一項に記載の方法。
- 反応が、tert−ブトキシドカリウム、及びリン酸カリウムの中から選ばれた塩基の存在下で行われる、請求項1〜4のいずれか一項に記載の方法。
- 1〜3モル塩基当量が使用される、又は3モル塩基当量が使用される、請求項1〜5のいずれか一項に記載の方法。
- 反応が、Pd(OAc)2、Pd(F6−acac)2、及びPd(acac)2の中から選ばれた触媒前駆体の存在下で行われる、又はPd(OAc)2触媒前駆体の存在下で行われる、請求項1〜6のいずれか一項に記載の方法。
- 式(II)の基体を基準にして、0.05〜2モル%の量の触媒が、反応で使用される、請求項1〜7のいずれか一項に記載の方法。
- 式(II)の基体を基準にして、0.15〜0.5モル%の量の触媒が、反応で使用される、請求項1〜8のいずれか一項に記載の方法。
- 反応が、PPh3、P(Cy)3、Josiphos、Xantphos、dppe、dppp、及びdppfからなる群から選ばれた反応用結合剤の存在下で行われる、又はXantphos反応用結合剤の存在下で行われる、請求項1〜9のいずれか一項に記載の方法。
- パラジウム触媒前駆体のモル量の0.5〜2倍の配位子のモル量が、使用される、請求項1〜10のいずれか一項に記載の方法。
- 酢酸パラジウム触媒前駆体のモル量の約0.5倍の配位子のモル量が、使用される、請求項1〜11のいずれか一項に記載の方法。
- 反応が、60℃と140℃の間で行われる、又は80℃と120℃の間で行われる、請求項1〜12のいずれか一項に記載の方法。
- 反応が、85℃と100℃の間で行われる、請求項1〜13のいずれか一項に記載の方法。
- 反応が、16〜30時間行われる、請求項1〜14のいずれか一項に記載の方法。
- 反応が、18〜20時間行われる、請求項1〜15のいずれか一項に記載の方法。
- 反応が、無水環境下で行われる、請求項1〜16のいずれか一項に記載の方法。
- 式(II):
の1−(6−メチルピリジン−3−イル)エタノンが、式(IV):
の中間体5−エチニル−2−メチルピリジンの転化により得られる、請求項1〜17のいずれか一項に記載の方法。 - 式(IV):
の中間体5−エチニル−2−メチルピリジンが、式(V):
の中間体6−メチルピリジン−3−イル トリフルオロメタンスルホネートの転化により得られる、請求項18に記載の方法。 - ステップ(a)が、DMF中で、塩基としてリン酸カリウム、触媒前駆体として酢酸パラジウム(II)、及び配位子としてXantphosの存在下で行われる、請求項1〜19のいずれか一項に記載の方法。
- このようにして得られた式(I):
の化合物1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノン又はその塩を精製するステップを更に含む、請求項1〜20のいずれか一項に記載の方法。 - 式(I)の1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノン又はその塩を調製するためのパラジウム触媒の使用。
- 式(I)の1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノン又はその塩を調製するためのXantphos配位子の使用。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000362A ITMI20110362A1 (it) | 2011-03-09 | 2011-03-09 | Procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib. |
ITMI2011A000362 | 2011-03-09 | ||
ITMI2011A000647 | 2011-04-15 | ||
IT000647A ITMI20110647A1 (it) | 2011-03-09 | 2011-04-15 | Procedimento migliorato per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib. |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012188414A true JP2012188414A (ja) | 2012-10-04 |
JP6067228B2 JP6067228B2 (ja) | 2017-01-25 |
Family
ID=43977032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012002845A Active JP6067228B2 (ja) | 2011-03-09 | 2012-01-11 | エトリコキシブの中間体、1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノンの調製方法の改良 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8664402B2 (ja) |
EP (1) | EP2497767B1 (ja) |
JP (1) | JP6067228B2 (ja) |
CN (1) | CN102731374B (ja) |
BR (1) | BR102012000721B8 (ja) |
ES (1) | ES2424250T3 (ja) |
IT (2) | ITMI20110362A1 (ja) |
MX (1) | MX2012000569A (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015511592A (ja) * | 2012-03-14 | 2015-04-20 | ザック システム エス.ピー.エー.ZaCh System S.p.A. | ケトスルホン誘導体の製造方法 |
WO2015198850A1 (ja) * | 2014-06-26 | 2015-12-30 | 住友化学株式会社 | フェノール化合物の製造方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20121947A1 (it) * | 2012-11-15 | 2014-05-16 | Erregierre Spa | Processo di sintesi di un intermedio nella produzione di etoricoxib |
ITVI20130014A1 (it) | 2013-01-22 | 2014-07-23 | Italiana Sint Spa | Procedimento molto efficiente per preparare un intermedio di etoricoxib |
CN103664754B (zh) * | 2013-11-08 | 2016-05-25 | 上海交通大学 | 制备1-(6-甲基吡啶-3-基)-2-[4-甲硫基-苯基]乙酮的方法 |
CN104045596B (zh) * | 2014-06-27 | 2017-03-22 | 成都克莱蒙医药科技有限公司 | 制备依托考昔中间体1‑(6‑甲基吡啶‑3‑基)‑2‑[4‑(甲磺酰基)苯基]乙酮的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6072073A (en) * | 1998-08-21 | 2000-06-06 | Yale University | Carbonyl arylations and vinylations using transition metal catalysts |
WO2003002118A1 (en) * | 2001-06-27 | 2003-01-09 | Merck Frosst Canada & Co. | Substituted 8-arylquinoline pde4 inhibitors |
JP2006504670A (ja) * | 2002-08-08 | 2006-02-09 | アムジエン・インコーポレーテツド | バニロイド受容体リガンドおよびそれの治療での使用 |
WO2008013277A1 (fr) * | 2006-07-27 | 2008-01-31 | Chugai Seiyaku Kabushiki Kaisha | Dérivé spirocétal à cycles accolés et utilisation de celui-ci comme médicament dans le traitement du diabète |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR015938A1 (es) * | 1997-09-25 | 2001-05-30 | Merck Sharp & Dohme | Procedimiento para preparar diaril piridinas utiles como inhibidores cox-2 y compuesto intermediario |
RS49945B (sr) * | 1998-04-24 | 2008-09-29 | Merck & Co.Inc., | Postupak za sintetizovanje inhibitora cox-2 |
ES2207536T3 (es) | 1999-07-27 | 2004-06-01 | Lonza Ag | Procedimiento para preparar 1-(6-metilpiridin-3-il)-2-((4-metilsulfonil)fenil)etanona. |
IT1315243B1 (it) * | 1999-10-15 | 2003-02-03 | Zambon Spa | Processo di ossidazione per la preparazione di intermedi utili nellasintesi di diarilpiridine |
TW200841879A (en) * | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
-
2011
- 2011-03-09 IT IT000362A patent/ITMI20110362A1/it unknown
- 2011-04-15 IT IT000647A patent/ITMI20110647A1/it unknown
-
2012
- 2012-01-11 ES ES12150831T patent/ES2424250T3/es active Active
- 2012-01-11 EP EP12150831.1A patent/EP2497767B1/en active Active
- 2012-01-11 JP JP2012002845A patent/JP6067228B2/ja active Active
- 2012-01-11 CN CN201210007751.7A patent/CN102731374B/zh active Active
- 2012-01-11 BR BR102012000721A patent/BR102012000721B8/pt active IP Right Grant
- 2012-01-11 US US13/348,371 patent/US8664402B2/en active Active
- 2012-01-11 MX MX2012000569A patent/MX2012000569A/es active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6072073A (en) * | 1998-08-21 | 2000-06-06 | Yale University | Carbonyl arylations and vinylations using transition metal catalysts |
WO2003002118A1 (en) * | 2001-06-27 | 2003-01-09 | Merck Frosst Canada & Co. | Substituted 8-arylquinoline pde4 inhibitors |
JP2006504670A (ja) * | 2002-08-08 | 2006-02-09 | アムジエン・インコーポレーテツド | バニロイド受容体リガンドおよびそれの治療での使用 |
WO2008013277A1 (fr) * | 2006-07-27 | 2008-01-31 | Chugai Seiyaku Kabushiki Kaisha | Dérivé spirocétal à cycles accolés et utilisation de celui-ci comme médicament dans le traitement du diabète |
Non-Patent Citations (2)
Title |
---|
JPN6015040390; Davies, Ian W.; Marcoux, Jean-Francois; Corley, Edward G.; Journet, Michel; Cai, Dong-Wei; Palucki,: 'A Practical Synthesis of a COX-2-Specific Inhibitor' Journal of Organic Chemistry 65(25), 2000, 8415-8420 * |
JPN6015040391; Kost, A. N.; Terent'ev, P. B.; Zavada, T.: 'Properties of the acetylene group bound to a pyridine ring' Doklady Akademii Nauk SSSR V130, 1960, P326-328 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015511592A (ja) * | 2012-03-14 | 2015-04-20 | ザック システム エス.ピー.エー.ZaCh System S.p.A. | ケトスルホン誘導体の製造方法 |
WO2015198850A1 (ja) * | 2014-06-26 | 2015-12-30 | 住友化学株式会社 | フェノール化合物の製造方法 |
JPWO2015198850A1 (ja) * | 2014-06-26 | 2017-05-25 | 住友化学株式会社 | フェノール化合物の製造方法 |
US9920004B2 (en) | 2014-06-26 | 2018-03-20 | Sumitomo Chemical Company, Limited | Method for producing phenolic compound |
Also Published As
Publication number | Publication date |
---|---|
CN102731374A (zh) | 2012-10-17 |
MX2012000569A (es) | 2012-09-10 |
ES2424250T3 (es) | 2013-09-30 |
BR102012000721A2 (pt) | 2013-07-23 |
EP2497767B1 (en) | 2013-05-29 |
BR102012000721B8 (pt) | 2022-01-04 |
US8664402B2 (en) | 2014-03-04 |
CN102731374B (zh) | 2015-05-06 |
JP6067228B2 (ja) | 2017-01-25 |
ITMI20110647A1 (it) | 2012-09-10 |
EP2497767A1 (en) | 2012-09-12 |
BR102012000721B1 (pt) | 2021-09-28 |
US20120232281A1 (en) | 2012-09-13 |
ITMI20110362A1 (it) | 2012-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6067228B2 (ja) | エトリコキシブの中間体、1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノンの調製方法の改良 | |
TW201139400A (en) | Process for the synthesis of ketobenzofuran derivatives | |
WO2009096202A1 (ja) | ハロ多環芳香族化合物及びその製造方法 | |
JP2005350474A (ja) | シロスタゾールの製造方法 | |
TWI774650B (zh) | 芳基化方法 | |
EP3487837B1 (en) | Process for the preparation of spiroheterocyclic pyrrolidine dione herbicides by means of the intermediate compound 2-(4-chloro-2,6-dimethyl-phenyl)acetic acid | |
KR102636758B1 (ko) | 치환된 벤조트라이아졸 페놀 | |
BRPI0618545B1 (pt) | processo para produção de carboxanilidas | |
JP6096465B2 (ja) | ペランパネルの中間体である2−アルコキシ−5−(ピリジン−2−イル)ピリジンの調製方法 | |
ES2546487T3 (es) | Procedimiento para la preparación de derivados de ácido aril- y heteroarilacético | |
KR102087160B1 (ko) | 피리딘 n-옥시드 및 그의 제조 방법 | |
US8742127B2 (en) | Production method of 6-halogeno-3-arylpyridine derivative | |
KR101554539B1 (ko) | 금속이 배제된 호기성 산화 아민화 반응을 이용한 아마이드 화합물의 제조방법 | |
WO2014073003A1 (en) | Single-step process for the preparation of aryl olefins | |
JP3387723B2 (ja) | 2−ニトロイミノヘキサヒドロ−1,3,5−トリアジン類の製造法 | |
EP1986985B1 (en) | Intermediates and process for the preparation of aromatic derivatives of 1-adamantane | |
CZ294344B6 (cs) | Způsob výroby arylamidů heteroaromatických karboxylových kyselin | |
CN104151278B (zh) | 1-苯基-2,3-萘二羧酸酐及其衍生物的合成方法 | |
US8765962B1 (en) | Very efficient process for preparing an intermediate of etoricoxib | |
KR101025758B1 (ko) | 신규한 베타 치환된 모리타-베일리스-힐만 에스테르의 입체선택적인 합성방법 | |
JPWO2018025590A1 (ja) | 含窒素複素環化合物の製造方法及び含窒素複素環化合物 | |
JP2011057575A (ja) | 4−ヒドロキシベンゾチオフェン誘導体の製造方法 | |
JP2013151460A (ja) | 4−トリフルオロメチルスルホニルイソキサゾール及びその製造法 | |
JP2014091690A (ja) | 2‐(3‐(トリフルオロメチルスルホニル)‐1h‐インドール−2‐イル)フェノール誘導体及びその製造法 | |
KR20140131677A (ko) | 설포닐 화합물을 이용한 α-케토 (시아노메틸렌)트리페닐포스포레인 화합물의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150109 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150917 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151007 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160106 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20160513 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160913 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20160913 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20161006 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161108 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161110 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20161202 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20161221 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6067228 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |